HRT Financial’s Bristol-Myers Squibb BMY Stock Holding History

HRT Financial’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$400K	Sell	6,600 -4,300	-39%	-$251K	﹤0.01%	2684
2025 Q4	$587K	Buy	+10,900	New	+$524K	﹤0.01%	2021
2020 Q3	–	Sell	-20,800	Closed	-$1.22M	–	1904
2020 Q2	$1.22M	Buy	+20,800	New	+$1.24M	0.04%	485

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's BMY Position: Q1 2026 in Review

HRT Financial increased its Bristol-Myers Squibb (BMY) stake by 943% in Q1 2026, buying an estimated $109M and bringing the position to 2,075,945 shares worth $126M. The position accounts for 0.31% of the portfolio, ranked #43.

HRT Financial first reported a position in BMY in Q4 2014 and has held it in 16 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

HRT Financial held 2,075,945 shares of Bristol-Myers Squibb worth $126M as of Q1 2026.
HRT Financial bought 1,876,844 Bristol-Myers Squibb shares in Q1 2026, an estimated $109M.
Bristol-Myers Squibb made up 0.31% of HRT Financial's portfolio in Q1 2026, its #43 holding.
HRT Financial first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 16 quarters since.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.